Polypid Ltd Stock
Polypid Ltd Stock price
Key metrics
| Market capitalization | $24.56m |
| Enterprise Value | $24.88m |
| P/E (TTM) P/E ratio | negative |
| P/B ratio (TTM) P/B ratio | 11.38 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-25.81m |
| Cash position | $9.70m |
| EPS (TTM) EPS | $-7.69 |
| P/E forward | negative |
Is Polypid Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
Polypid Ltd Stock Analysis
Analyst Opinions
4 Analysts have issued a Polypid Ltd forecast:
Analyst Opinions
4 Analysts have issued a Polypid Ltd forecast:
Financial data from Polypid Ltd
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -26 -26 |
10%
10%
|
| Net Profit | -27 -27 |
12%
12%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Polypid Ltd directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Polypid Ltd Stock News
Company Profile
PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform. Its products include D-PLEX, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX100 for the prevention of post-abdominal surgery incisional infection; BONYPID-1000, an antibiotic eluting ß tri-calcium phosphate granule for bone related infections applications; and BONYPID500, an antibiotic eluting bone graft substitute that fills and reconstructs periodontal and oral/maxillofacial defects, while protecting from infections. PolyPid Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel.
| Head office | Israel |
| CEO | Dikla Akselbrad |
| Employees | 62 |
| Founded | 2008 |
| Website | www.polypid.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
